Status:

UNKNOWN

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries

Lead Sponsor:

Boston Scientific Corporation

Collaborating Sponsors:

Cardialysis BV

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

21+ years

Phase:

PHASE3

Brief Summary

The SYNTAX trial is designed to determine the best treatment for patients with complex coronary disease (blocked or narrowed arteries in both the right and left sides of the heart) by randomizing pati...

Detailed Description

Due to the introduction of drug-eluting stents (DESs) and to improvements in therapy for both percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG) patients, PCI is challe...

Eligibility Criteria

Inclusion

  • Three-vessel disease, left main disease or LM equivalent with or without 1, 2 or 3VD (left anterior descending \[LAD\], left circumflex \[LCX\], right coronary artery \[RCA\] territory)
  • De novo lesions with at least 50% stenosis
  • Myocardial ischemia (stable, unstable, silent)

Exclusion

  • Prior PCI or CABG
  • Acute myocardial infarction (with creatinine kinase \>2x upper limit of normal)
  • Concomitant cardiac valve disease requiring surgical therapy (reconstruction or replacement)
  • Participation or planned participation in another cardiovascular clinical study before 1 year follow-up is completed
  • Inability to give informed consent due to mental condition, mental retardation, or language barrier

Key Trial Info

Start Date :

March 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2012

Estimated Enrollment :

1800 Patients enrolled

Trial Details

Trial ID

NCT00114972

Start Date

March 1 2005

End Date

May 1 2012

Last Update

June 23 2010

Active Locations (106)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 27 (106 locations)

1

Mercy General Hospital

Sacramento, California, United States, 95819

2

Washington Hospital Center

Washington D.C., District of Columbia, United States, 20010

3

Florida Cardiovascular Research

Atlantis, Florida, United States, 33462

4

Munroe Medical Center

Ocala, Florida, United States, 34474